换一批
换一批
作者：
Izanne,Roos [1]
;
Ibrahima,Diouf [2]
;
Sifat,Sharmin [2]
;
Dana,Horakova [3]
;
Eva Kubala,Havrdova [3]
;
Francesco,Patti [4]
;
Vahid,Shaygannejad [5]
;
Serkan,Ozakbas [6]
;
Guillermo,Izquierdo [7]
;
Sara,Eichau [7]
;
Marco,Onofrj [8]
;
Alessandra,Lugaresi [9]
;
Raed,Alroughani [10]
;
Alexandre,Prat [11]
;
Marc,Girard [11]
;
Pierre,Duquette [11]
;
Murat,Terzi [12]
;
Cavit,Boz [13]
;
Francois,Grand'Maison [14]
;
Patrizia,Sola [15]
;
Diana,Ferraro [15]
;
Pierre,Grammond [16]
;
Recai,Turkoglu [17]
;
Katherine,Buzzard [18]
;
Olga,Skibina [19]
;
Bassem,Yamou [20]
;
Ayse,Altintas [21]
;
Oliver,Gerlach [22]
;
Vincent,van Pesch [23]
;
Yolanda,Blanco [24]
;
Davide,Maimone [25]
;
Jeannette,Lechner-Scott [26]
;
Roberto,Bergamaschi [27]
;
Rana,Karabudak [28]
;
Chris,McGuigan [29]
;
Elisabetta,Cartechini [30]
;
Michael,Barnett [31]
;
Stella,Hughes [32]
;
Maria José,Sa [33]
;
Claudio,Solaro [34]
;
Cristina,Ramo-Tello [35]
;
Suzanne,Hodgkinson [36]
;
Daniele,Spitaleri [37]
;
Aysun,Soysal [38]
;
Thor,Petersen [39]
;
Franco,Granella [40]
;
Koen,de Gans [41]
;
Pamela,McCombe [42]
;
Radek,Ampapa [43]
;
Bart,Van Wijmeersch [44]
;
Anneke,van der Walt [45]
;
Helmut,Butzkueven [45]
;
Julie,Prevost [46]
;
Jose Luis,Sanchez-Menoyo [47]
;
Guy,Laureys [48]
;
Riadh,Gouider [49]
;
Tamara,Castillo-Triviño [50]
;
Orla,Gray [51]
;
Eduardo,Aguera-Morales [52]
;
Abdullah,Al-Asmi [53]
;
Cameron,Shaw [54]
;
Norma,Deri [55]
;
Talal,Al-Harbi [56]
;
Yara,Fragoso [57]
;
Tunde,Csepany [58]
;
Angel Perez,Sempere [59]
;
Irene,Trevino-Frenk [60]
;
Jan,Schepel [61]
;
Fraser,Moore [62]
;
Charles,Malpas [1]
;
Tomas,Kalincik [1]
作者单位：
CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
[1]
CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
[2]
Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
[3]
Department of Medical and Surgical Sciences and Advanced Technologies, G.F. Ingrassia, Catania, Italy/Multiple Sclerosis Center, University of Catania, Catania, Italy.
[4]
Isfahan University of Medical Sciences, Isfahan, Iran.
[5]
Dokuz Eylul University, İzmir, Turkey.
[6]
Hospital Universitario Virgen Macarena, Sevilla, Spain.
[7]
University G. d'Annunzio, Chieti, Italy.
[8]
Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy/IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
[9]
Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
[10]
CHUM MS Center and Universite de Montreal, Montreal, QC, Canada.
[11]
19 Mayis University, Samsun, Turkey.
[12]
KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
[13]
Neuro Rive-Sud, Greenfield Park, QC, Canada.
[14]
Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
[15]
CISSS Chaudière-Appalache, Levis, QC, Canada.
[16]
Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
[17]
Department of Neurology, Box Hill Hospital, Melbourne, VIC, Australia/Monash University, Melbourne, VIC, Australia/Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.
[18]
Department of Neurology, Box Hill Hospital, Melbourne, VIC, Australia/The Alfred Hospital, Melbourne, VIC, Australia.
[19]
Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
[20]
Department of Neurology, School of Medicine and Koc University Research Center for Translational Medicine (KUTTAM), Koc University, Istanbul, Turkey.
[21]
Zuyderland Medical Center, Sittard-Geleen, The Netherlands/School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
[22]
Cliniques Universitaires Saint-Luc, Brussels, Belgium/Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.
[23]
Center of Neuroimmunology, Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain.
[24]
Centro Sclerosi Multipla, UOC Neurologia, ARNAS Garibaldi, Catania, Italy.
[25]
School of Medicine and Public Health, University Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
[26]
IRCCS Mondino Foundation, Pavia, Italy.
[27]
Hacettepe University, Ankara, Turkey.
[28]
St. Vincent's University Hospital, Dublin, Ireland.
[29]
UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
[30]
Brain and Mind Centre, Sydney, NSW, Australia.
[31]
Royal Victoria Hospital, Belfast, UK.
[32]
Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.
[33]
Department of Neurology, ASL3 Genovese, Genova, Italy/Department of Rehabilitation, M.L. Novarese Hospital Moncrivello, Moncrivello, Italy.
[34]
Hospital Germans Trias i Pujol, Badalona, Spain.
[35]
Immune Tolerance Laboratory, Ingham Institute and Department of Medicine, University of New South Wales, Sydney, NSW, Australia.
[36]
Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
[37]
Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
[38]
Aarhus University Hospital, Aarhus, Denmark.
[39]
Department of Medicine and Surgery, University of Parma, Parma, Italy/Department of Emergency and General Medicine, Parma University Hospital, Parma, Italy.
[40]
Groene Hart Ziekenhuis, Gouda, The Netherlands.
[41]
The University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
[42]
Nemocnice Jihlava, Jihlava, Czech Republic.
[43]
Rehabilitation & MS Centre, University MS Centre, Noorderhart Hospital, Pelt, Belgium/Pelt and Hasselt University, Hasselt, Belgium.
[44]
Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/Central Clinical School, Monash University, Clayton, VIC, Australia.
[45]
CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
[46]
Hospital de Galdakao-Usansolo, Galdakao, Spain.
[47]
Department of Neurology, University Hospital Ghent, Ghent, Belgium.
[48]
Department of Neurology, Razi Hospital, Manouba, Tunisia.
[49]
Hospital Universitario Donostia and IIS Biodonostia, San Sebastián, Spain.
[50]
South Eastern HSC Trust, Belfast, UK.
[51]
University Hospital Reina Sofia, Cordoba, Spain.
[52]
Department of Medicine, Sultan Qaboos University Hospital, Al-Khodh, Oman.
[53]
Geelong Hospital, Geelong, VIC, Australia.
[54]
Hospital Fernandez, Capital Federal, Buenos Aires, Argentina.
[55]
Neurology Department, King Fahad Specialist Hospital-Dammam, Khobar, Saudi Arabia.
[56]
Universidade Metropolitana de Santos, Santos, Brazil.
[57]
Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
[58]
Hospital General Universitario de Alicante, Alicante, Spain.
[59]
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
[60]
Waikato Hospital, Hamilton, New Zealand.
[61]
Jewish General Hospital, Montreal, QC, Canada.
[62]
主题词
人类(Humans);多发性硬化(Multiple Sclerosis);免疫抑制剂(Immunosuppressive Agents);免疫因子类(Immunologic Factors);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);治疗结果(Treatment Outcome);倾向性评分(Propensity Score);复发(Recurrence)
DOI
10.1177/13524585231151394
PMID
36800908
发布时间
2023-04-17
- 浏览0
Multiple sclerosis (Houndmills, Basingstoke, England)
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
